Hermetica Superfood Encyclopedia
The Short Answer
Abalone peptides from Haliotis discus—including the octapeptide DEDEDEDK and the decapeptide KVEPQDPSEW (AATP)—exert antioxidant effects by disrupting the Keap1–Nrf2 interaction and anti-tumor effects by suppressing ERK/JNK/NF-κB signaling and downregulating MMP and VEGF expression. All mechanistic evidence to date derives exclusively from in vitro cell-line studies; DEDEDEDK restored HUVEC viability and boosted SOD and glutathione levels in oxidatively damaged cells at concentrations of 125–1000 μg/mL, but no human clinical trials have been conducted.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordabalone peptides benefits
Abalone Peptides — botanical close-up
Health Benefits
**Antioxidant Defense**
The peptide DEDEDEDK binds the Kelch domain of Keap1, disrupting Keap1–Nrf2 complex formation and enabling Nrf2-driven upregulation of superoxide dismutase, catalase, and glutathione in AAPH-damaged HUVECs at 125–1000 μg/mL.
**Anti-Tumor Activity**
The decapeptide AATP (KVEPQDPSEW) dose-dependently suppresses PMA-induced expression of MMP-1, -2, -3, -9, and -13 and inhibits invasion and migration in HT1080 fibrosarcoma cells through ERK/JNK pathway suppression.
**Anti-Metastatic Potential**
AATP blocks vasculogenic mimicry (VM) in HT1080 cells by downregulating VEGF and HIF-1α; molecular docking confirms hydrogen-bond interactions with HIF-1α, interrupting angiogenic signaling critical for tumor spread.
**NF-κB Pathway Modulation**
AATP inhibits p65 nuclear translocation and NF-κB DNA-binding activity, reducing pro-inflammatory and pro-tumorigenic gene transcription in fibrosarcoma cell models.
**Endothelial Cytoprotection**
Select peptides including EDE, FEPETTEEVR, DASCK, and DTSTMGYMAAK exhibit no cytotoxicity up to 1000 μg/mL in HUVECs and support endothelial cell growth under oxidative challenge conditions.
**Anti-Fatigue Potential**
Water-soluble protein hydrolysates from related Haliotis species have shown anti-fatigue properties in preclinical models, attributed to their capacity to reduce oxidative stress and replenish antioxidant enzyme activity in metabolically stressed tissues.
**Byproduct Bioactivity**
Boiled abalone visceral byproducts retain measurable anti-tumor and antioxidant activity, suggesting that thermal processing preserves at least a portion of bioactive peptide sequences and their functional properties.
Origin & History
Natural habitat
Haliotis discus is a species of large marine gastropod mollusk native to the coastal waters of East Asia, particularly Japan, Korea, and China, where it inhabits rocky subtidal zones at depths of 5–40 meters. The animal is commercially aquacultured across these regions, with Japan and China representing the largest producers; bioactive peptides are derived primarily from visceral byproducts and muscle tissue generated during food processing. Peptide fractions are obtained through enzymatic hydrolysis or boiling of abalone tissue rather than from the whole animal consumed traditionally.
“Abalone (Haliotis spp.) has been consumed as a prestigious seafood in East Asian culinary and medicinal traditions for over a millennium, featuring prominently in Chinese, Japanese, and Korean cuisine as a food associated with longevity, vitality, and reproductive health in folk practice. In Traditional Chinese Medicine, dried abalone (Shi Jue Ming) refers primarily to the shell of Haliotis species, which was prescribed for conditions such as headache, hypertension, and visual disturbances, though this use is pharmacologically distinct from the soft-tissue peptide fractions now under scientific investigation. The viscera and processing byproducts historically considered waste in commercial aquaculture operations have only recently been recognized as a source of bioactive peptides, driven by valorization research beginning in the early 2000s. No traditional preparation method specifically targeting peptide-rich fractions from H. discus soft tissue is documented; the peptide-focused science is entirely a product of modern marine biotechnology.”Traditional Medicine
Scientific Research
The entirety of published research on Haliotis discus peptides is confined to in vitro studies using established cell lines—primarily human umbilical vein endothelial cells (HUVECs) for antioxidant assessment and HT1080 human fibrosarcoma cells for anti-tumor evaluation—with no in vivo animal studies or human clinical trials reported in the accessible literature. The antioxidant study employed a virtual enzymatic hydrolysis library of 363 candidate peptides screened computationally before cell-based validation, representing a methodologically rigorous discovery pipeline but one that has not progressed to animal or human testing. Anti-tumor data for AATP relied on Western blotting, zymography, invasion assays, and molecular docking to characterize mechanism, but numeric effect sizes and formal sample sizes beyond experimental replicates are not reported in available summaries. The overall evidence base is preliminary and preclinical; translation to human pharmacology, effective oral doses, and safety in living organisms remains entirely unestablished.
Preparation & Dosage
Traditional preparation
**Enzymatic Hydrolysate (Research Form)**
Produced by virtual or enzymatic hydrolysis of abalone viscera or muscle; in vitro effective concentrations range from 3.9 to 1000 μg/mL—no equivalent oral dose for humans has been established.
**Boiled Byproduct Extract**
Thermal processing of abalone visceral waste retains anti-tumor and antioxidant peptide activity; exact bioactive concentrations in boiled preparations are not quantified in current literature.
**Water-Soluble Protein Extract**
Related Haliotis species yield water-soluble extracts used in preclinical anti-fatigue models; no standardized extract ratio or concentration specification is available for Haliotis discus specifically.
**Commercial Supplement Forms**
No standardized commercial abalone peptide supplement derived specifically from Haliotis discus with verified DEDEDEDK or AATP content is currently documented in the peer-reviewed literature.
**Standardization**
No standardization percentage, marker compound specification, or certificate-of-analysis benchmark has been established for any commercial or research-grade abalone peptide product.
**Timing and Administration Notes**
Oral bioavailability of intact bioactive sequences such as DEDEDEDK and AATP has not been studied; peptide stability under gastrointestinal digestion conditions is unknown and represents a critical unresolved question.
Nutritional Profile
Abalone muscle tissue is a high-quality protein source providing approximately 18–20 g protein per 100 g fresh weight, with a favorable essential amino acid profile rich in glutamic acid, aspartic acid, and lysine—the residue classes prominently represented in identified bioactive peptides such as DEDEDEDK. The viscera contain lipid fractions including omega-3 polyunsaturated fatty acids (EPA and DHA), though concentrations vary with feed and season in aquacultured animals. Micronutrient content includes iron, zinc, selenium, and iodine at levels consistent with marine mollusks, alongside vitamin B12 and small amounts of vitamin E. Bioavailability of intact bioactive peptide sequences from dietary consumption is uncharacterized; gastrointestinal proteolysis may degrade or transform DEDEDEDK and AATP before systemic absorption, making the nutritional and pharmacological profiles of whole abalone consumption distinct from purified peptide supplementation.
How It Works
Mechanism of Action
DEDEDEDK exerts its primary antioxidant mechanism by docking into the Kelch-repeat domain of Keap1 (PDB: 2FLU) at coordinates x: 5.000222, y: 7.103889, z: 5.058000 via CDOCKER molecular docking, competitively disrupting the Keap1–Nrf2 protein–protein interaction and allowing Nrf2 to translocate to the nucleus and activate antioxidant response element (ARE)-driven genes encoding SOD, catalase, and glutathione synthetic enzymes. AATP (KVEPQDPSEW) targets the MAPK cascade by reducing phosphorylation of ERK1/2 and JNK, simultaneously suppressing NF-κB activation through inhibition of p65 nuclear translocation and its DNA-binding capacity, which collectively downregulates the transcription of matrix metalloproteinases (MMP-1/-2/-3/-9/-13) and vascular endothelial growth factor (VEGF). AATP further interacts with HIF-1α via hydrogen bonding as shown by molecular docking, impairing hypoxia-inducible transcriptional programs that drive vasculogenic mimicry and angiogenesis in tumor microenvironments. The net outcome of these pathways is reduced cellular oxidative burden, attenuated proteolytic remodeling of the extracellular matrix, and inhibition of the pro-metastatic signaling network in vitro.
Clinical Evidence
No human clinical trials have been conducted on abalone peptides derived from Haliotis discus or its close relative Haliotis discus hannai. The existing evidence base consists solely of in vitro experiments in which DEDEDEDK significantly increased HUVEC viability and antioxidant enzyme activities versus AAPH-damaged controls at 125–1000 μg/mL (p < 0.05 to p < 0.01), and AATP suppressed MMP expression and vasculogenic mimicry in HT1080 fibrosarcoma cells in a dose-dependent manner. No effect sizes expressed as standardized mean differences, confidence intervals, or clinically interpretable metrics have been published for any endpoint. Confidence in translational efficacy is very low; these peptides should be regarded as early-discovery bioactive candidates requiring progression through animal pharmacokinetic and toxicology studies before any clinical relevance can be determined.
Safety & Interactions
In vitro cytotoxicity screening demonstrated that key peptides DEDEDEDK, EDE, FEPETTEEVR, DASCK, and DTSTMGYMAAK are non-toxic to HUVECs at concentrations up to 1000 μg/mL, while the peptide DDIMEDKDNF reduced HUVEC viability to 76.11 ± 4.35% at 1000 μg/mL, indicating that not all abalone peptide sequences are equally safe even at the cellular level. No in vivo toxicology studies, no human safety data, no maximum tolerated dose, and no no-observed-adverse-effect level (NOAEL) have been established for any Haliotis discus peptide fraction, making comprehensive safety characterization impossible at this time. Drug interactions have not been studied; theoretically, peptides modulating NF-κB or MAPK pathways could interact with immunosuppressants or chemotherapeutic agents, but this is speculative and unvalidated. Use during pregnancy or lactation cannot be recommended given the complete absence of reproductive toxicology data; individuals with shellfish allergies should exercise particular caution, as cross-reactivity with abalone-derived protein fractions is plausible.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Haliotis discus hannai peptidesAbalone hydrolysateAbalone bioactive peptidesAATP (KVEPQDPSEW)Disk abalone peptidesEzo abalone extract
Frequently Asked Questions
What are abalone peptides and what do they do?
Abalone peptides are short amino acid sequences derived from the enzymatic hydrolysis or thermal processing of Haliotis discus tissue, including the octapeptide DEDEDEDK and the decapeptide KVEPQDPSEW (AATP). DEDEDEDK has demonstrated antioxidant activity in cell studies by blocking the Keap1–Nrf2 interaction, while AATP suppresses tumor cell migration and invasion by inhibiting MMP enzymes and VEGF signaling. All current evidence is from laboratory cell studies; no human trials have been conducted.
Is there clinical evidence that abalone peptides work in humans?
No human clinical trials have been published for abalone peptides from Haliotis discus; the entire evidence base consists of in vitro experiments in cell lines such as HUVECs and HT1080 fibrosarcoma cells. While these studies show statistically significant effects on antioxidant enzymes (p < 0.05) and tumor cell behavior at concentrations of 125–1000 μg/mL, these findings cannot be directly extrapolated to human physiology. Progression through animal pharmacokinetic and toxicology studies would be required before clinical use could be evaluated.
What is the recommended dosage for abalone peptide supplements?
No standardized human dose has been established for abalone peptides, as all dosing data comes from in vitro cell culture experiments using concentrations of 3.9–1000 μg/mL—units that do not translate directly to oral supplement doses. Oral bioavailability of intact sequences like DEDEDEDK and AATP has not been studied, and it is unknown whether these peptides survive gastrointestinal digestion intact. Any commercial product claiming a specific effective dose for abalone peptides currently lacks clinical validation.
Are abalone peptide supplements safe to take?
The primary bioactive peptides DEDEDEDK, EDE, and FEPETTEEVR showed no cytotoxicity in human endothelial cells up to 1000 μg/mL in vitro, but comprehensive safety data including animal toxicology studies, human adverse event reports, and drug interaction profiles are entirely absent. Some abalone peptide sequences, such as DDIMEDKDNF, did reduce cell viability at higher concentrations, highlighting that not all fractions are equally benign. People with shellfish allergies, pregnant or breastfeeding individuals, and those on immunosuppressants or chemotherapy should avoid abalone peptide supplements until safety data are available.
How are abalone peptides different from regular abalone extract?
Regular abalone extract typically refers to a broad protein or lipid-rich fraction from Haliotis species tissue, while abalone peptides specifically denotes short amino acid sequences (typically 2–10 residues) obtained through enzymatic hydrolysis or thermal processing of abalone viscera or muscle. Identified bioactive peptides like DEDEDEDK and AATP have defined sequences with characterized molecular targets (Keap1, HIF-1α, MMPs), whereas crude extracts contain a mixture of proteins, polysaccharides, and lipids without peptide-level specificity. The peptide-focused research represents a more precise, mechanistically characterized approach compared to traditional whole-extract preparations.
Can abalone peptides help with skin health and collagen production?
Abalone peptides, particularly bioactive sequences like DEDEDEDK, demonstrate antioxidant activity through Nrf2 pathway activation, which supports cellular defense mechanisms relevant to skin aging. While research has focused primarily on antioxidant and anti-inflammatory pathways rather than direct collagen synthesis, the peptides' ability to reduce oxidative stress in endothelial cells suggests potential indirect benefits for skin integrity and wound healing. However, direct clinical evidence specifically measuring collagen production or skin elasticity improvements in humans remains limited.
How do abalone peptides compare to marine collagen peptides for anti-aging benefits?
Abalone peptides and marine collagen peptides differ significantly in their mechanisms: abalone peptides work primarily through antioxidant pathways (Nrf2 activation) and matrix metalloproteinase inhibition, while collagen peptides provide structural amino acids for connective tissue synthesis. Abalone peptides show potent anti-inflammatory activity by suppressing MMP expression, whereas collagen peptides focus on providing building blocks for tissue repair. The choice depends on whether your primary goal is oxidative stress reduction (abalone) or structural collagen replenishment (marine collagen).
What is the bioavailability of abalone peptides compared to whole abalone extract?
Abalone peptides are pre-hydrolyzed into small molecular weight chains (typically 2-10 amino acids), enabling superior absorption in the small intestine compared to larger protein molecules in whole abalone extract. The peptide form allows specific bioactive sequences like DEDEDEDK and KVEPQDPSEW to be more readily available for cellular uptake and mechanism-specific activity. This increased bioavailability is why research studies use isolated peptides at lower concentrations (125–1000 μg/mL) to achieve measurable biological effects that whole extract would require in much larger doses.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w abalone-peptides-haliotis-discus curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
